Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults with AIDS-related Kaposi sarcoma after failure of highly active antiretroviral therapy, or Kaposi sarcoma in adults without HIV.
LAMPGEN ANALYSIS
Why it matters
Added an oral option for two Kaposi sarcoma populations under accelerated approval.
What research teams should watch
Coordinate HIV history and prior antiretroviral therapy documentation with protocol-required safety checks.
PRIMARY RECORDS